Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;100(9):432-5.
doi: 10.1177/014107680710000923.

Capitalizing on Mendelian randomization to assess the effects of treatments

Affiliations
Review

Capitalizing on Mendelian randomization to assess the effects of treatments

George Davey Smith. J R Soc Med. 2007 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intention to treat analysis of children with leukaemia

Comment in

Similar articles

Cited by

References

    1. Gray R, Wheatley K. How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant 1991. ;7(Suppl 3):9 -12 - PubMed
    1. Ljungman P, De Witte T, Verdonck L, et al. Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing. Br J Haematol 1993;84:61 -66 - PubMed
    1. Keating S, de Witte T, Suciu S, et al. The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMENA. Br J Haematol 1998. ;102:1344 -53 - PubMed
    1. Burnett AK, Wheatley K, Goldstone AH, et al. The value of allogenic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol 2002;118:385 -400 - PubMed
    1. Harrison G, Richards S, Lawson S, et al. on behalf of the MRC Childhood Leukaemia Working Party. Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. Ann Oncol 2000. ;11:999 -1006 - PubMed

Publication types